Say it with Pride

During the month of June, people all over the world come together to celebrate Pride Month and to raise awareness of the LGBTQIA+ community. At Chanelle Pharma, we always strive for equality inclusivity and diversity as well as a commitment to ensuring everyone feels respected, valued, and appreciated. To celebrate Pride Month, our National Account […]

Chanelle Pharma announces successful compilation of new Bisoprolol tablets dossier.

Chanelle Pharma announces successful compilation of new Bisoprolol tablets dossier. Chanelle Pharma is pleased to announce that we have successfully finalised a new dossier for Bisoprolol (1.25mg, 2.5mg, 3.75mg, 5mg, 7.5mg, and 10mg). A β-Blocker medication, Bisoprolol is considered a key therapeutic option for people with Heart failure, Hypertension, and Angina. Chanelle previously launched Bisoprolol […]

Chanelle Pharma Makes Senior Appointments, strengthening leadership team.

Chanelle Pharma is pleased to announce the appointment of Aubrey Mulveen to the new position of Chief Financial Officer (CFO). Aubrey joins from C&D Foods, a division of ABP Group, one of Ireland’s largest and most successful family run businesses, where he has been CFO for the last six years.  Aubrey brings extensive experience in […]

From Loughrea to the USA – Chanelle Pharma continues to expand its Global reach 

Chanelle Pharma is delighted to announce it has shipped its first products to the US market following the granting of accreditation by the US Food and Drugs Administration (FDA) for its Spot On manufacturing facility in Loughrea, Co Galway.